nomida semaglutide for diabetes tied to increased NAION risk Health Rounds: Novo Nordisk's semaglutide

This happened when totally inconsistent results were published by several groups using JNK2-deficient mice [36, 134136] and it was later discovered that the reason for the contradictory data was caused by the mislabeling of the background strain for JNK2 KO mice by the vendor [137], which led to the use of WT and KO mice with mismatched genetic background

Delayed gastric emptying For people on medications such as hormonal birth control, Zepbounds effects on digestion may be significant

For patients who have already tried GLP-1 therapy, adding an amylin pathway intervention targets different receptors and different brain regions, which is what makes the combination genuinely additive

Epigenetics 2010